Literature DB >> 4051850

Long-term follow-up of argon laser trabeculoplasty for uncontrolled open-angle glaucoma.

A L Schwartz, D C Love, M A Schwartz.   

Abstract

Between May 1978 and October 1981, 82 phakic eyes in 72 patients with uncontrolled open-angle glaucoma underwent 360 degrees argon laser trabeculoplasty. Continued long-term follow-up has shown a decreasing pressure-lowering effect. The peak pressure lowering was 9.7 mm Hg at two months, 7.3 mm Hg at two years, 6.8 mm Hg at four years, and 4.9 mm Hg at five years. In 1982, we reported a 77% success rate, but, after five years of observation, the success rate is 46%. However, our clinical population is unique in that the majority of our patients (57%) are black. The most important factor in the long-term success rate appears to be race. Only 32% of cases involving black patients were successful, while 65% of cases involving white patients were successful. A Kaplan-Meier survival curve analysis revealed that the median time to an intraocular pressure greater than 21 mm Hg was 12 months for black patients and 60 months for white patients.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4051850     DOI: 10.1001/archopht.1985.01050100058018

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  25 in total

1.  Long term follow-up of the argon laser trabeculoplasty in eyes treated 180 degrees and 360 degrees of the trabeculum.

Authors:  F M Honrubia; E J Ferrer; J Leciñena; C Torrón; M L Gómez
Journal:  Int Ophthalmol       Date:  1992-09       Impact factor: 2.031

2.  Diode laser trabeculoplasty (DLT) for primary open-angle glaucoma and ocular hypertension.

Authors:  D McHugh; J Marshall; T J Ffytche; P A Hamilton; A Raven
Journal:  Br J Ophthalmol       Date:  1990-12       Impact factor: 4.638

3.  [Medicinal glaucoma therapy. What can we learn from large randomized clinical trials?].

Authors:  A G M Jünemann; C Huchzermeyer; R Rejdak
Journal:  Ophthalmologe       Date:  2013-12       Impact factor: 1.059

4.  Argon laser trabeculoplasty controls one third of patients with progressive, uncontrolled open-angle glaucoma for five years.

Authors:  K A Baez; G L Spaeth
Journal:  Trans Am Ophthalmol Soc       Date:  1991

Review 5.  Medical treatment of glaucoma--a reappraisal of the risks.

Authors:  P Diggory; W Franks
Journal:  Br J Ophthalmol       Date:  1996-01       Impact factor: 4.638

6.  Efficacy of argon laser trabeculoplasty: 3-year preliminary results of a prospective placebo-controlled study.

Authors:  C Ustundag; M Diestelhorst
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-06       Impact factor: 3.117

Review 7.  Glaucoma blindness in African Americans: have 55 years of therapies, technologies, and talent altered blindness rates?

Authors:  J C Merritt
Journal:  J Natl Med Assoc       Date:  1996-12       Impact factor: 1.798

8.  Prevention of the immediate intraocular pressure rise following argon laser trabeculoplasty.

Authors:  T W Metcalfe; D E Etchells
Journal:  Br J Ophthalmol       Date:  1989-08       Impact factor: 4.638

9.  Glaucoma in the black population: a problem of blindness.

Authors:  K C Greenidge; M Dweck
Journal:  J Natl Med Assoc       Date:  1988-12       Impact factor: 1.798

10.  Late failures of trabeculoplasty.

Authors:  F Moulin; J Haut; J Abi Rached
Journal:  Int Ophthalmol       Date:  1987-02       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.